{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:00:56Z","timestamp":1762297256333},"reference-count":56,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.vaccine.2007.09.053","type":"journal-article","created":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T12:17:11Z","timestamp":1194610631000},"page":"8420-8431","source":"Crossref","is-referenced-by-count":26,"title":["Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate"],"prefix":"10.1016","volume":"25","author":[{"given":"Mait\u00e9","family":"Delgado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Yero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Niebla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanet","family":"Climent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusleydis","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karem","family":"Cobas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evel\u00edn","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darien","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Paj\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2007.09.053_bib1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0950268800066449","article-title":"The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica","volume":"99","author":"Cartwright","year":"1987","journal-title":"Epidemiol Infect"},{"issue":"Suppl. 12","key":"10.1016\/j.vaccine.2007.09.053_bib2","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1097\/01.inf.0000147642.85129.05","article-title":"Global epidemiology of meningococcal disease and vaccine efficacy","volume":"23","author":"Pollard","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.vaccine.2007.09.053_bib3","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.293.12.1433","article-title":"New vaccine should ease meningitis fears","volume":"293","author":"Mitka","year":"2005","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2007.09.053_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","article-title":"Immunologic response of man to group B meningococcal polysaccharide vaccines","volume":"126","author":"Wyle","year":"1972","journal-title":"J Infect Dis"},{"issue":"8346","key":"10.1016\/j.vaccine.2007.09.053_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2007.09.053_bib6","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen","year":"1991","journal-title":"NIPH Ann"},{"issue":"2","key":"10.1016\/j.vaccine.2007.09.053_bib7","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"issue":"8775","key":"10.1016\/j.vaccine.2007.09.053_bib8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.vaccine.2007.09.053_bib9","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.053_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2958.1991.tb00743.x","article-title":"Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis","volume":"5","author":"Maiden","year":"1991","journal-title":"Mol Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.09.053_bib11","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1128\/JCM.36.12.3680-3682.1998","article-title":"Heterogeneity of the PorB protein in serotype 22 Neisseria meningitidis","volume":"36","author":"Urwin","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.053_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/514232","article-title":"Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland","volume":"177","author":"Perkins","year":"1998","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2007.09.053_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tibtech.2004.12.008","article-title":"The impact of genomics on vaccine design","volume":"23","author":"Scarselli","year":"2005","journal-title":"Trends Biotechnol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.053_bib14","first-page":"216","article-title":"Proteomics approaches towards antigen discovery and vaccine development","volume":"4","author":"Klade","year":"2002","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.vaccine.2007.09.053_bib15","first-page":"115","article-title":"Exploring and exploiting bacterial proteomes","volume":"266","author":"Cordwell","year":"2004","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.09.053_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/1615-9861(200205)2:5<580::AID-PROT580>3.0.CO;2-G","article-title":"Identification of vaccine candidate antigens of Staphylococcus aureus aureus by serological proteome analysis","volume":"2","author":"Vytvytska","year":"2002","journal-title":"Proteomics"},{"issue":"18","key":"10.1016\/j.vaccine.2007.09.053_bib17","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1002\/pmic.200401326","article-title":"Immunoproteomics of outer membrane proteins and extracellular proteins of Shigella flexneri 2a 2457T","volume":"5","author":"Ying","year":"2005","journal-title":"Proteomics"},{"issue":"11","key":"10.1016\/j.vaccine.2007.09.053_bib18","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1128\/IAI.72.11.6471-6479.2004","article-title":"Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis","volume":"72","author":"Mollenkopf","year":"2004","journal-title":"Infect Immun"},{"issue":"5459","key":"10.1016\/j.vaccine.2007.09.053_bib19","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1126\/science.287.5459.1809","article-title":"Complete genome sequence of Neisseria meningitidis serogroup B strain MC58","volume":"287","author":"Tettelin","year":"2000","journal-title":"Science"},{"issue":"5459","key":"10.1016\/j.vaccine.2007.09.053_bib20","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"issue":"29","key":"10.1016\/j.vaccine.2007.09.053_bib21","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2007.09.053_bib22","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2007.09.053_bib23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.vaccine.2007.09.053_bib24","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/pmic.200400946","article-title":"Proteome analysis of Neisseria meningitidis serogroup A","volume":"4","author":"Bernardini","year":"2004","journal-title":"Proteomics"},{"issue":"11","key":"10.1016\/j.vaccine.2007.09.053_bib25","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1002\/pmic.200500821","article-title":"Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98\/254","volume":"6","author":"Vipond","year":"2006","journal-title":"Proteomics"},{"issue":"11","key":"10.1016\/j.vaccine.2007.09.053_bib26","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1002\/pmic.200500502","article-title":"Outer membrane vesicles of the VA-MENGOC-BC(R) vaccine against serogroup B of Neisseria meningitidis: analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry","volume":"6","author":"Uli","year":"2006","journal-title":"Proteomics"},{"issue":"25","key":"10.1016\/j.vaccine.2007.09.053_bib27","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1016\/j.vaccine.2006.03.013","article-title":"Proteomic analysis of Neisseria lactamica and Neisseria meningitidis outer membrane vesicle vaccine antigens","volume":"24","author":"Vaughan","year":"2006","journal-title":"Vaccine"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2007.09.053_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/BA20050170","article-title":"Bicistronic expression plasmid for the rapid production of recombinant fused proteins in Escherichia coli","volume":"44","author":"Yero","year":"2006","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.vaccine.2007.09.053_bib29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nbt1184-979","article-title":"Dehydration rehydration vesicles: a simple method for high yield drug entrapment in liposomes","volume":"2","author":"Kirby","year":"1984","journal-title":"Biotechnology"},{"issue":"2","key":"10.1016\/j.vaccine.2007.09.053_bib30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/IAI.51.2.571-578.1986","article-title":"Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting","volume":"51","author":"Wedege","year":"1986","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2007.09.053_bib31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1699-0463.1990.tb01063.x","article-title":"Serogroup determination of Neisseria meningitidis by whole-cell ELISA, dot-blotting and agglutination","volume":"98","author":"Rosenqvist","year":"1990","journal-title":"APMIS"},{"issue":"2","key":"10.1016\/j.vaccine.2007.09.053_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.09.053_bib33","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.vaccine.2004.07.032","article-title":"Immunization of mice with Neisseria meningitidis serogroup B genomic expression libraries elicits functional antibodies and reduces the level of bacteremia in an infant rat infection model","volume":"23","author":"Yero","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.053_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0092-8674(88)90162-6","article-title":"A single amino acid determinant of the membrane localization of lipoproteins in E. coli","volume":"53","author":"Yamaguchi","year":"1988","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.vaccine.2007.09.053_bib35","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1128\/jb.173.17.5523-5531.1991","article-title":"A gene for a new lipoprotein in the dapA-purC interval of the Escherichia coli chromosome","volume":"173","author":"Bouvier","year":"1991","journal-title":"J Bacteriol"},{"issue":"21","key":"10.1016\/j.vaccine.2007.09.053_bib36","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1128\/JB.184.21.5826-5832.2002","article-title":"Recognition of DNA by Fur: a reinterpretation of the Fur box consensus sequence","volume":"184","author":"Baichoo","year":"2002","journal-title":"J Bacteriol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.09.053_bib37","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.vaccine.2005.11.006","article-title":"Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens","volume":"24","author":"Jacobsson","year":"2005","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2007.09.053_bib38","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1128\/JB.187.13.4552-4561.2005","article-title":"Characterization of six lipoproteins in the sigmaE regulon","volume":"187","author":"Onufryk","year":"2005","journal-title":"J Bacteriol"},{"issue":"23","key":"10.1016\/j.vaccine.2007.09.053_bib39","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1128\/JB.183.23.6794-6800.2001","article-title":"Genetic evidence for parallel pathways of chaperone activity in the periplasm of Escherichia coli","volume":"183","author":"Rizzitello","year":"2001","journal-title":"J Bacteriol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.09.053_bib40","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1128\/IAI.73.9.6075-6084.2005","article-title":"Characterization of the dapA-nlpB genetic locus involved in regulation of swarming motility, cell envelope architecture, hemolysin production, and cell attachment ability in Serratia marcescens","volume":"73","author":"Soo","year":"2005","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.053_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2958.2006.05211.x","article-title":"YfiO stabilizes the YaeT complex and is essential for outer membrane protein assembly in Escherichia coli","volume":"61","author":"Malinverni","year":"2006","journal-title":"Mol Microbiol"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2007.09.053_bib42","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1016\/S0264-410X(01)00008-1","article-title":"Immunogenicity of recombinant class 1 protein from Neisseria meningitidis refolded into phospholipid vesicles and detergent","volume":"19","author":"Niebla","year":"2001","journal-title":"Vaccine"},{"issue":"6\u20137","key":"10.1016\/j.vaccine.2007.09.053_bib43","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0264-410X(96)00198-3","article-title":"Recombinant Opc meningococcal protein, folded in vitro, elicits bactericidal antibodies after immunization","volume":"15","author":"Musacchio","year":"1997","journal-title":"Vaccine"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2007.09.053_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1042\/BA20010029","article-title":"Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers","volume":"34","author":"Perez","year":"2001","journal-title":"Biotechnol Appl Biochem"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2007.09.053_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/08830180009088505","article-title":"Vaccination in the neonatal period and early infancy","volume":"19","author":"Siegrist","year":"2000","journal-title":"Int Rev Immunol"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2007.09.053_bib46","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/S0264-410X(01)00028-7","article-title":"Neonatal and early life vaccinology","volume":"19","author":"Siegrist","year":"2001","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2007.09.053_bib47","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0264-410X(95)00011-O","article-title":"Adjuvants for human vaccines\u2014current status, problems and future prospects","volume":"13","author":"Gupta","year":"1995","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2007.09.053_bib48","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2007.09.053_bib49","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1099\/00221287-144-11-3027","article-title":"Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci","volume":"144","author":"Christodoulides","year":"1998","journal-title":"Microbiology"},{"issue":"8","key":"10.1016\/j.vaccine.2007.09.053_bib50","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1128\/IAI.70.8.4028-4034.2002","article-title":"Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis","volume":"70","author":"Wright","year":"2002","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2007.09.053_bib51","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0264-410X(97)00015-7","article-title":"Immunogenicity and protectivity of a new liposomal hepatitis A vaccine","volume":"15","author":"Ambrosch","year":"1997","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.09.053_bib52","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0264-410X(97)00260-0","article-title":"Immunogenicity of liposome-associated and refined antigen oral cholera vaccines in Thai volunteers","volume":"16","author":"Chaicumpa","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.09.053_bib53","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/IAI.67.2.618-623.1999","article-title":"A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responses","volume":"67","author":"Childers","year":"1999","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2007.09.053_bib54","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.185.7.1173","article-title":"Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection","volume":"185","author":"Martin","year":"1997","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2007.09.053_bib55","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1074\/jbc.M411232200","article-title":"The Neisseria meningitidis outer membrane lipoprotein FrpD binds the RTX protein FrpC","volume":"280","author":"Prochazkova","year":"2005","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.vaccine.2007.09.053_bib56","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T23:03:42Z","timestamp":1708297422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07011012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":56,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0264410X07011012"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.09.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}